FDA Grants Priority Review for Nalmefene Prefilled Syringe for the Treatment of Known or Suspected Opioid Overdose

BeiGene Sees Expanded Coverage on China's National Reimbursement Drug List

Teon Therapeutics Forges Clinical Trial Collaboration with Merck to Evaluate TT-816, a Novel Oral Immune Response Modifier, in Combination with Keytruda

Airsupra Approved in the US for Asthma

Amylyx Pharmaceuticals signs exclusive AMX0035 sistribution agreement with Neopharm

AstraZeneca's Tezspire approved for self-administration in the EU in a new pre-filled pen

First Patient Dosed in Adaptive Phage Therapeutics' PHAGE Clinical Trial Evaluating Phage Therapy in Cystic Fibrosis-related Respiratory Infection

Cambrian BioPharma launches Isterian Biotech

CF Foundation Invests Up to USD 15m in ReCode Therapeutics for Development of mRNA Therapy

Inogen Achieves Regulatory Milestones to Support Current and Future Products

Novavax names new president and chief executive officer and member of the board of directors

Cantex Pharmaceuticals' azeliragon receives US FDA Orphan Drug Designation to treat glioblastoma

Arthrosi Therapeutics reveals positive top-line results from of AR882 Phase 2b clinical study

European Medicines Agency Validates Marketing Authorization Application for Trodelvy for Pre-treated HR+/HER2- Metastatic Breast Cancer

hVIVO wins GBP5.2m contract for RSV vaccine trial